Losing Medical Talent To Competitors? 42 Medical Leaders Say Training Matters
CHAPEL HILL, N.C., Mar. 04, 2020/PRNewswire/ -- As the importance of the Medical Affairs function continues to grow, top biopharma companies have developed high-impact training and development programs to help Medical Affairs professionals succeed in their critical, multifaceted roles.
A new Best Practices, LLC study involving 42 biopharma organizations found that all companies ranked role rotation as critical for developing future medical leaders; however, close to 50% companies do not have a formal role rotation program.
The 68-page study examines best-in-class practices that leading biopharma organizations have implemented to create effective knowledge development and program timing. The study also examines staffing and funding for training programs.
The study, "Best Practices for Training and Developing High-Impact Medical Affairs Professionals," will help companies maximize the benefits of their training and development programs, producing Medical Affairs staff capable of strong strategic thinking, critical communication with internal and external stakeholders, effective thought leader management, and high-impact field interactions.
Training and development leaders in medical affairs can use this study to compare their programs with those at best-in-class companies.
This study includes three data segments: Total Benchmark Class, 57; More Mature Segment, 29; and Less Mature Segment, 28
Topics addressed in this study include:
- Training Oversight & Approvals
- Training Curriculum
- Knowledge Development
- Onboarding Programs
- Timing & Performance
- Staffing and Funding
- MSL Certification
To learn more about this research, download a complimentary report excerpt at https://www.best-in-class.com/rw99.htm.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.